73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

by Kyoto UniversityThe CAR construct impacts the differentiation of CAR-iPSCs into T-cell lineages. a, Schematic presentation of the CAR constructs 19z, 1928z, 19bbz, 1928bbz and w/oED28z CAR (w/

Genetic modifications improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors

by Kyoto UniversityThe CAR construct impacts the differentiation of CAR-iPSCs into T-cell lineages. a, Schematic presentation of the CAR constructs 19z, 1928z, 19bbz, 1928bbz and w/oED28z CAR (w/
Small device for earlier ovarian cancer detection

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de
How Leukemia Is Treated

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu

How Leukemia Is Treated

How Leukemia Is TreatedByKaren RaymaakersUpdated on January 22, 2023Medically reviewed byDouglas A. Nelson, MDThe treatment forleukemiadepends on many factors inclu
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Study suggests new strategies against bone metastases from prostate cancer

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe

Study suggests new strategies against bone metastases from prostate cancer

by Garth Sundem,CU Anschutz Medical CampusWhen prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 pe
Smoking duration, intensity tied to bladder cancer recurrence

Smoking duration, intensity tied to bladder cancer recurrence

by Lori SolomonLonger duration and more pack-years of cigarette smoking are associated with a higher risk for recurrence of non-muscle-invasive bladder cancer (NMIBC), according to a study published o

Smoking duration, intensity tied to bladder cancer recurrence

by Lori SolomonLonger duration and more pack-years of cigarette smoking are associated with a higher risk for recurrence of non-muscle-invasive bladder cancer (NMIBC), according to a study published o
Common hair loss and prostate drug may also cut heart disease risk

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die

Common hair loss and prostate drug may also cut heart disease risk

by Lauren Quinn,University of Illinois at Urbana-ChampaignFinasteride decreases plaque size and macrophage content in Ldlr-/-mice. Four-week-old male Ldlr-/-mice were fed Western die
Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,
Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res
Blood test spots early pancreatic cancers with 97% accuracy

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN

Blood test spots early pancreatic cancers with 97% accuracy

by Dennis ThompsonA blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DN
Evaluating brain tumors with artificial intelligence

Evaluating brain tumors with artificial intelligence

byTechnische Universitat DarmstadtCredit: Pixabay/CC0 Public DomainAn international team of researchers from TU Darmstadt, the University of Cambridge, the science and technology company Merck,

Evaluating brain tumors with artificial intelligence

byTechnische Universitat DarmstadtCredit: Pixabay/CC0 Public DomainAn international team of researchers from TU Darmstadt, the University of Cambridge, the science and technology company Merck,
Researchers create new cancer fighting compound

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3